Craft

Azenta

Stock Price

$51.3

2024-05-14

Market Capitalization

$2.8 B

2024-05-14

Revenue

$665.1 M

FY, 2023

Azenta Summary

Company Summary

Overview
Azenta Life Sciences (formerly known as Brooks Automation) is a provider of biological and chemical compound sample exploration and management capabilities for the life sciences industry. It operates in two business segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage systems, consumable vials and tubes, controlled rate thawing devices, and temperature-controlled storage and transportation systems. The Life Sciences Services segment delivers genomic and sample repository solutions.
Type
Public
Status
Active
Founded
1978
HQ
Burlington, MA, US | view all locations
Website
https://www.azenta.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Stephen S. Schwartz

    Stephen S. Schwartz, President & Chief Executive Officer

  • Herman Cueto

    Herman Cueto, Executive Vice President & Chief Financial Officer

  • Jason W. Joseph

    Jason W. Joseph, Senior Vice President, General Counsel & Corporate Secretary

  • Olga Pirogova

    Olga Pirogova, Senior Vice President and Chief Human Resources Officer

Operating MetricsView all

Countries

180
100.0%

Q1, 2023

Enterprise Customers (GENEWIZ)

4K

FY, 2021

Backlog (Brooks Life Sciences Services)

$235M

FY, 2020

LocationsView all

30 locations detected

  • Burlington, MA HQ

    United States

    200 Summit Dr

  • Billerica, MA

    United States

    159 Rangeway Rd

  • Cleveland, OH

    United States

    9808 Cedar Ave

  • Fresno, CA

    United States

    1849 N Helm Ave STE 102A

  • Indianapolis, IN

    United States

    2910 Fortune Cir W Suite E

  • Indianapolis, IN

    United States

    2920 Fortune Cir W Suite A

and 24 others

Azenta Financials

Summary Financials

Revenue (Q2, 2024)
$159.1M
Gross profit (Q2, 2024)
$63.4M
Net income (Q2, 2024)
($136.9M)
Cash (Q2, 2024)
$353.5M
EBIT (Q2, 2024)
($147.0M)
Enterprise value
$2.5B

Footer menu